An Open-Label Study of CAR-T-BCMA&PD-1 Cells in treatment of Relapsed or Refractory Multiple Myeloma

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2019
This article has no abstract
Epistemonikos ID: 2af1f08e3c4816369485bf9a09ee5b0663c0263b
First added on: Apr 07, 2025